Cerebrovascular Disorders (Disease Or Phenotype)

Omim:MTHU038116

Nci:C2938

Msh:D002561

Mondo:MONDO:11057

Medcin:MEDCIN:337489

Mdr:MDR:10008198

Lnc:LA31446-0

Id:7b1892f2-73cf-5b5e-a2d0-110d5075abc9

Icpc2icd10eng:MTHU043409

Icd10cm:I67.9

Efo:EFO:3763

Doid:DOID:6713

Chv:CHV:2681

Results found

Linked to

	Label	Description
	atp binding correlated with condition Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Cysteine correlated with condition Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Guanosine triphosphate correlated with condition Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate correlated with condition Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	3-Hydroxyanthranilic Acid correlated with condition Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Bencyclane indication Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	tolazoline indication Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	SID11112417 indication Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	docosahexaenoic acid correlated with condition Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	ADP correlated with condition Cerebrovascular Disorders Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics

atp binding correlated with condition Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Cysteine correlated with condition Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Guanosine triphosphate correlated with condition Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate correlated with condition Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

3-Hydroxyanthranilic Acid correlated with condition Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Bencyclane indication Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

tolazoline indication Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

SID11112417 indication Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

docosahexaenoic acid correlated with condition Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

ADP correlated with condition Cerebrovascular Disorders

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.